If you developed serious medical complications after taking a GLP-1 drug such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Saxenda, Victoza, or Zepbound, you may qualify for a legal claim. Thousands of patients nationwide are undergoing case evaluations involving injuries doctors have linked to slowed digestion, dehydration, pancreatic inflammation, and organ damage.
This page is the primary intake gateway for anyone seeking to verify whether their symptoms meet claim criteria.
Do I Qualify for a GLP-1 Weight Loss Drug Lawsuit (Ozempic, Mounjaro, etc.)?
If you’re considering a potential claim involving GLP-1 medications such as Ozempic or Mounjaro, there are several threshold criteria that generally need to be met. Below is a practical overview of what law firms are currently evaluating when screening these cases.
Baseline Eligibility Requirement Criteria for a GLP-1 lawsuit (Ozempic lawsuit)
To be considered for a GLP-1 gastrointestinal injury case, you should meet the following:
Use of a Brand-Name GLP-1 Medication
You must have been prescribed and taken a brand-name GLP-1 drug manufactured by Novo Nordisk or Eli Lilly. Compounded versions do not qualify.
Acceptable medications include:
- Mounjaro (tirzepatide) – Eli Lilly
- Ozempic (semaglutide) – Novo Nordisk
- Rybelsus (semaglutide tablets) – Novo Nordisk
- Victoza (liraglutide) – Novo Nordisk
- Saxenda (liraglutide) – Novo Nordisk
- Trulicity (dulaglutide) – Eli Lilly
- Wegovy (semaglutide) – Novo Nordisk
- Zepbound (tirzepatide) – Eli Lilly
Proof is required, typically in the form of prescription records, pharmacy receipts, or physician documentation.
Qualifying Injury or Diagnosis: You must have experienced a serious medical condition requiring treatment, emergency care, or hospitalization. Common qualifying injuries include:
- Bowel obstruction or ileus
- Necrotizing pancreatitis
- Severe gastroparesis (stomach paralysis)
- Persistent vomiting requiring ER care or IV fluids
- Gastrointestinal injury requiring surgery
- Esophageal injury requiring surgery
- Deep vein thrombosis (in well-controlled diabetics)
- Pancreatic cancer (with no prior history)
- Intraoperative pulmonary aspiration
- Gallbladder removal (subject to timing and label warnings—see below)
- Neuropathy occurring alongside gastroparesis (case-by-case review)
Supporting documentation—hospital records, ER visits, and specialist treatment (e.g., gastroenterology)—is essential.
- No Prior Bariatric Surgery
- Individuals with a history of weight loss or bariatric surgery are generally excluded.
- No Recent Abdominal Radiation
- Radiation treatment to the abdominal area within 12 months before symptom onset will typically disqualify a claim.
Prescription Timeline
You will need to provide the date the medication was first prescribed.
No Compounded Drugs
Claims involving compounded GLP-1 medications are not being accepted.
Additional Notes on Specific Injuries
Gallbladder Cases:
Claims involving gallbladder removal may be limited if the prescription began after the March 2022 label update. Timing matters, and statute of limitations issues may apply depending on the state.
Gastroparesis Claims:
A formal diagnosis is typically required. In some cases, a gastric emptying study may be necessary, although hospitalization alone may suffice depending on the reviewing firm.
Neuropathy + Gastroparesis:
These cases are being closely scrutinized. If neuropathy predates gastroparesis, eligibility is evaluated on a case-by-case basis.
Vision Injury / NAION Lawsuit Criteria
There is a growing number of claims involving vision loss and optic nerve injuries associated with GLP-1 medications. To qualify, the following factors are typically considered:
- Qualifying Vision Injuries
- Sudden vision changes (with formal diagnosis)
- Sudden blindness (partial or complete)
- Optic nerve stroke (NAION)
- Retinal stroke
- Loss of visual acuity
- Color vision loss
- Ischemia to the optic nerve
- Wet macular degeneration
- Timing Requirement
- The vision-related injury generally must occur within approximately 30 days of GLP-1 drug use or dosage change.
Exclusions:
Claims based solely on the following are typically not accepted:
- Floaters
- Diabetic retinopathy
- Cataracts
- Glaucoma
Exception: These conditions may still be considered if accompanied by sudden blindness or a confirmed NAION diagnosis.
Bottom Line
GLP-1 litigation is evolving quickly, and eligibility often comes down to documentation, timing, and the severity of the injury. Even where a claim appears to meet these criteria, additional legal and medical review is always required before a case can move forward.
Who This Evaluation Is For
You may be eligible if you took a GLP-1 medication and later developed any of the following:
Digestive System Injuries
- diagnosed gastroparesis
- persistent vomiting
- inability to tolerate normal meals
- severe bloating or fullness after small meals
- intestinal obstruction or motility shutdown
Pancreatic Injuries
- pancreatitis
- recurring abdominal pain requiring medical care
- pancreatic damage after inflammation
Kidney Injuries
- acute kidney injury (AKI)
- reduced kidney filtration rates
- long-term kidney decline
- dialysis treatment
Gallbladder & Biliary Issues
- gallstones
- bile duct obstruction
- gallbladder inflammation
- gallbladder removal surgery
Other Severe Harm Indicators
- repeated ER visits for dehydration
- diagnosed nutritional deficiencies
- feeding tube reliance
- extended work disruption
- permanent impairment
If one or more apply, a claim review may be appropriate.
The Claim Review Process
Your eligibility review examines:
- Medical diagnosis
- Dates you used the medication
- When symptoms began
- Imaging, GI testing, or kidney labs
- Hospitalization records
- Surgeries or interventions
- Whether the condition is ongoing
If your situation aligns with known risk patterns, you may be considered a qualifying claimant.
Information Commonly Requested
During intake screening, most case reviewers look for:
- proof of GLP-1 prescription or dispensing
- medical documentation of injuries
- gastroenterology, renal, or surgical records
- ER summaries
- test results:
- gastric emptying scans
- pancreatic enzyme labs
- kidney filtration testing
- gallbladder imaging
If you do not have these documents yet, medical teams can often help you request them.
Signs You Should Seek a Review Immediately
Claim reviewers consider symptoms high-priority when patients experience:
- weeks or months of vomiting
- inability to maintain nutrition
- dramatic weight loss
- multiple ER or urgent-care visits
- diagnosis of gastroparesis or pancreatitis
- measurable kidney function decline
- gallbladder removal surgery
- bowel blockage or pseudo-obstruction
These patterns are frequently seen in current filings.
Why People File Claims
Individuals pursuing claims generally report:
- permanent digestive disability
- chronic organ problems
- long-term treatment costs
- feeding restrictions
- reduced quality of life
- missed work
- emotional strain
Legal reviews determine whether injuries fit recognized adverse-event patterns associated with GLP-1 medications.
What Compensation May Include
Depending on circumstances, compensation may address:
- medical bills
- ER visits
- surgeries or feeding support
- dialysis treatment
- long-term care
- lost income
- disability
- reduced earning ability
- pain and suffering
- lifestyle disruption
Financial recovery varies based on documentation and the extent of long-term harm.
No Obligation Case Screening
A claim review does not require filing a lawsuit.
Many begin simply to determine whether their medical condition aligns with known injury patterns and whether compensation may be available.
Conditions Most Often Qualifying
Cases involving the following injuries have shown the strongest eligibility signals:
- confirmed gastroparesis
- diagnosed pancreatitis
- acute or chronic kidney injury
- intestinal obstruction
- gallbladder surgery
- multi-organ stress caused by dehydration
- long-term GI impairment that did not resolve after stopping the drug
If your doctor suspects a drug-related injury, a review is strongly recommended.
How to Strengthen Your Review
If possible, gather:
- diagnosis records
- surgical notes
- hospital summaries
- scan/imaging results
- test results (kidney or pancreatic)
- GI motility findings
- prescription history
These help case reviewers determine strength and eligibility.
➡️ Guidance: Medical Records
Additional Eligibility Resources
If You’re Ready to Begin
If you suffered a severe medical complication that you believe may be connected to Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Saxenda, Victoza, or Zepbound, a claim review can help determine whether legal options apply.
Check Eligibility
You can begin by answering a few simple questions about:
- the GLP-1 drug used
- symptoms or diagnosis
- how long the drug was taken
- medical treatment received
➡️ Start Your Case Review
Begin Eligibility Questionnaire